Pathogens of Nonhuman Primates

doi:10.1128/9781555817824.ch11

Chapter 11 : Pathogens of Nonhuman Primates

Author: David G. Baker¹

VIEW AFFILIATIONS HIDE AFFILIATIONS

Affiliations: 1: School of Veterinary Medicine, Louisiana State University, Baton Rouge, Louisiana

Content Type: Reference

Publication Year: 2003

Category: Clinical Microbiology

Book DOI: 10.1128/9781555817824

Chapter DOI: 10.1128/9781555817824.ch11

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:

Pathogens of Nonhuman Primates, Page 1 of 2

< Previous page | Next page > /docserver/preview/fulltext/10.1128/9781555817824/9781555812669_Chap11-1.gif /docserver/preview/fulltext/10.1128/9781555817824/9781555812669_Chap11-2.gif

Abstract:

This chapter deals with the most commonly identified primate pathogens. When any of these pathogens are diagnosed, the laboratory animal veterinarian and the scientific investigator should discuss the infection in light of the intended use of the animal(s). It is an especially difficult task to assess retrospectively the effects of pathogens on primate physiology. Hepatitis B virus (HBV) is one of several important hepatitis viruses known to infect, and to be named after, specific animal hosts such as woodchucks, ducks, and ground squirrels. Diagnosis of HBV is complicated by the lack of clinical signs. Respiratory syncytial virus (RSV), also known as ‘‘chimpanzee coryza,’’ is a single-stranded RNA (ssRNA) virus in the family Paramyxoviridae, subfamily Pneumovirinae. In some cases of Simian retrovirus type D (SRV/D) infection, resulting immune suppression facilitates infection with a wide range of opportunistic pathogens. The subsequent profound immune compromise allows for infection with opportunistic pathogens, particularly pyogenic bacteria. Prevention of infection with other pathogens, particularly immune-suppressive viruses, will help ensure that SV40 does not adversely affect host physiology. Shigella flexneri is among the most common bacterial pathogens of captive primates. Balantidium coli is a protozoan parasite and member of the Class Ciliophora. Most members of the class are free living and nonparasitic, or are parasitic and symbiotic. In this regard, some humans infected with B. coli experience bloodloss anemia in addition to nutrient malabsorption.

Citation: Baker D. 2003. Pathogens of Nonhuman Primates, p 341-376. In Natural Pathogens of Laboratory Animals. ASM Press, Washington, DC. doi: 10.1128/9781555817824.ch11

Highlighted Text: Show | Hide

Full text loading...

References

/content/book/10.1128/9781555817824.chap11

1. Adams, S. R.,, E. Muchmore,, and J. H. Richardson,. 1995. Biosafety, p. 375– 420. In B. T. Bennett, , C. R. Abee, , and R. Henrickson (ed.), Nonhuman Primates in Biomedical Research. Biology and Management. Academic Press, Inc., San Diego, Calif.

2. Gibson, S. V., 1998. Bacterial and mycotic diseases, p. 59– 110. In B. T. Bennett, , C. R. Abee, , and R. Henrickson (ed.), Nonhuman Primates in iomedical Research. Diseases. Academic Press, Inc., San Diego, Calif.

3. Mansfield, K.,, and N. King,. 1998. Viral diseases, p. 1– 57. In B. T. Bennett, , C. R. Abee, , and R. Henrickson (ed.), Nonhuman Primates in Biomedical Research. Diseases. Academic Press, Inc., San Diego, Calif.

4. Toft, J. D., II,, and M. L. Eberhard,. 1998. Parasitic diseases, p. 111– 205. In B. T. Bennett, , C. R. Abee, , and R. Henrickson (ed.), Nonhuman Primates in Biomedical Research. Diseases. Academic Press, Inc., San Diego, Calif.

1. Bancroft, W. H.,, R. Snitbhan,, R. M. Scott,, M. Tingpalonpong,, W. T. Watson,, P. Tanticharoenyos,, J. J. Karwacki,, and S. Srimarut. 1977. Transmission of hepatitis B virus to gibbons by exposure to human saliva containing hepatitis B surface antigen. J. Infect. Dis. 135: 79– 85.

2. Dienstag, J. L.,, H. Popper,, and R. H. Purcell. 1976. The pathology of viral hepatitis types A and B in chimpanzees. Am. J. Pathol. 85: 131– 148.

3. Guidotti, L. G.,, R. Rochford,, J. Chung,, M. Shapiro,, R. Purcell,, and F. V. Chisari. 1999. Viral clearance without destruction of infected cells during acute HBV infection. Science. 284: 825– 829.

4. Hu, X.,, A. Javadian,, P. Gagneux,, and B. H. Robertson. 2001. Paired chimpanzee hepatitis B virus (ChHBV) and mtDNA sequences suggest different ChHBV genetic variants are found in geographically distinct chimpanzee subspecies. Virus Res. 79: 103– 108.

5. Karasawa, T.,, T. Shikata,, K. Abe,, R. Kondo,, M. Noro,, and T. Oda. 1985. Ultrastructural studies on liver cell necrosis and lymphocytes in experimental hepatitis B. Acta. Pathol. Jpn. 35: 1359– 1374.

6. Kornegay, R. W., , W. E. Giddens, Jr.,, G. L. Van Hoosier, Jr.,, and W. R. Morton. 1985. Subacute nonsuppurative hepatitis associated with hepatitis B infection in two cynomolgus monkeys. Lab. Anim. Sci. 35: 400– 404.

7. Lafrado, L. J.,, M. A. Javadian,, J. M. Marr,, K. A. Wright,, J. C. Kelliher,, C. S. Dezzutti,, L. Cummins,, and R. G. Olsen. 1991. Lymphocyte and neutrophil dysfunction associated with hepatitis B virus and hepatitis non-A, non-B virus infection in the chimpanzee. J. Med. Primatol. 20: 302– 307.

8. Lieberman, H. M.,, W. W. Tung,, and D. A. Shafritz. 1987. Splenic replication of hepatitis B virus in the chimpanzee chronic carrier. J. Med. Virol. 21: 347– 359.

9. Mansfield, K.,, and N. King,. 1998. Viral diseases, p. 1– 57. In B. T. Bennett, , C. R. Abee, , and R. Henrickson (ed.), Nonhuman Primates in Biomedical Research. Diseases. Academic Press, Inc., San Diego, Calif.

10. Prince, A. M.,, R. Whalen,, and B. Brotman. 1997. Successful nucleic acid based immunization of newborn chimpanzees against hepatitis B virus. Vaccine 15: 916– 919.

11. Scalise, G.,, M. R. Mazaheri,, J. Kremastinou,, C. R. Howard,, K. Sorensen,, and A. J. Zuckerman. 1978. Transmission of hepatitis B to the rhesus monkey. Studies on the humoral and cell-mediated immune response. J. Med. Primatol. 7: 114– 118.

12. Scott, R. M.,, R. Snitbhan,, W. H. Bancroft,, H. J. Alter,, and M. Tingpalapong. 1980. Experimental transmission of hepatitis B virus by semen and saliva. J. Infect. Dis. 142: 67– 71.

13. Sly, D. L.,, W. T. London,, and R. H. Purcell. 1979. Illness in a chimpanzee inoculated with hepatitis B virus. J. Am. Vet. Med. Assoc. 175: 987– 988.

1. Carlson, C. S.,, M. G. O’Sullivan,, M. J. Jayo,, D. K. Anderson,, E. S. Harber,, W. G. Jerome,, B. C. Bullock,, and R. L. Heberling. 1997. Fatal disseminated cercopithecine herpesvirus 1 (herpes B) infection in cynomolgus monkeys ( Macaca fascicularis). Vet. Pathol. 34: 405– 414.

2. Holmes, G. P.,, L. E. Chapman,, J. A. Stewart,, S. E. Strauss,, J. K. Hilliard,, and D. S. Davenport. 1995. Guidelines for the prevention and treatment of B-virus infections in exposed persons. The B virus Working Group. Clin. Infect. Dis. 29: 421– 439.

3. Mansfield, K.,, and N. King,. 1998. Viral diseases, p. 1– 57. In B. T. Bennett, , C. R. Abee, , and R. Henrickson (ed.) , Nonhuman Primates in Biomedical Research. Diseases. Academic Press, Inc., San Diego, Calif.

4. Simon, M. A.,, M. D. Daniel,, D. Lee-Parritz,, N. W. King,, and D. J. Ringler. 1993. Disseminated B virus infection in a cynomolgus monkey. Lab. Anim. Sci. 43: 545– 550.

5. Ward, J. A.,, and J. K. Hilliard. 2002. Herpes B virus-specific pathogen-free breeding colonies of macaques: serologic test results and the B-virus status of the macaque. Contemp. Top. Lab. Anim. Sci. 41: 36– 41.

6. Weigler, B. J.,, D. W. Hird,, J. K. Hilliard,, N. W. Lerche,, J. A. Roberts,, and L. M. Scott. 1993. Epidemiology of Cercopithecine herpesvirus 1 (B virus) infection and shedding in a large breeding cohort of rhesus macaques. J. Infect. Dis. 167: 257– 263.

7. Weigler, B. J.,, F. Scinicariello,, and J. K. Hilliard. 1995. Risk of venereal B virus (cercopithecine herpesvirus 1) transmission in rhesus monkeys using molecular epidemiology. J. Infect. Dis. 171: 1139– 1143.

8. Weir, E. C.,, P. N. Bhatt,, R. O. Jacoby,, J. K. Hilliard,, and S. Morgenstern. 1993. Infrequent shedding and transmission of Herpesvirus simiae from seropositive macaques. Lab. Anim. Sci. 43: 541.A

1. Belshe, R. B.,, L. S. Richardson,, W. T. London,, D. T. Sly,, J. H. Lorfeld,, E. Camargo,, D. A. Prevar,, and R. M. Chanock. 1977. Experimental respiratory syncytial virus infection of four species of primates. J. Med. Virol. 1: 157– 162.

2. Brown, G.,, H. W. Rixon,, and R. J. Sugrue. 2002. Respiratory syncytial virus assembly occurs in GM1-rich regions of the host-cell membrane and alters the cellular distribution of tyrosine phosphorylated caveolin-1. J. Gen. Virol. 83: 1841– 1850.

3. Clarke, C. J.,, N. J. Watt,, A. Meredith,, N. McIntyre,, and S. M. Burns. 1994. Respiratory syncytial virus-associated bronchopneumonia in a young chimpanzee. J. Comp. Pathol. 110: 207– 212.

4. Hickling, T. P.,, R. Malhotra,, H. Bright,, W. McDowell,, E. D. Blair,, and R. B. Sim. 2000. Lung surfactant protein A provides a route of entry for respiratory syncytial virus into host cells. Viral Immunol. 13: 125– 135.

5. Jaovisidha, P.,, M. E. Peeples,, A. A. Brees,, L. R. Carpenter,, and J. N. Moy. 1999. Respiratory syncytial virus stimulates neutrophil degranulation and chemokine release. J. Immunol. 163: 2816– 2820.

6. Johnston, I. D. 1999. Effect of pneumonia in childhood on adult lung function. J. Pediatr. 135: 33– 37.

7. Mansfield, K.,, and N. King,. 1998. Viral diseases, p. 1– 57. In B. T. Bennett, , C. R. Abee, , and R. Henrickson (ed.), Nonhuman Primates in Biomedical Research. Diseases. Academic Press, Inc., San Diego, Calif.

8. Mastronarde, J. G.,, B. He,, M. M. Monick,, N. Mukaida,, K. Matsushima,, and G. W. Hunninghake. 1996. Induction of interleukin (IL)-8 gene expression by respiratory syncytial virus involves activation of nuclear factor (NF)- κB and NF-IL-8. J. Infect. Dis. 174: 262– 267.

9. McArthur-Vaughan, K.,, and L. J. Gershwin. 2002. A rhesus monkey model of respiratory syncytial virus infection. J. Med. Primatol. 31: 61– 73.

10. McBride, J. T. 1999. Pulmonary function changes in children after respiratory syncytial virus infection in infancy. J. Pediatr. 135: 28– 32.

11. Ponnuraj, E. M.,, A. R. Hayward,, A. Raj,, H. Wilson,, and E. A. Simoes. 2001. Increased replication of respiratory syncytial virus (RSV) in pulmonary infiltrates is associated with enhanced histopathological disease in bonnet monkeys ( Macaca radiata) pre-immunized with a formalin-inactivated RSV vaccine. J. Gen. Virol. 82: 2663– 2674.

12. Raza, M. W.,, C. C. Blackwell,, R. A. Elton,, and D. M. Weir. 2000. Bactericidal activity of a monocytic cell line (THP-1) against common respiratory tract bacterial pathogens is depressed after infection with respiratory syncytial virus. J. Med. Microbiol. 49: 227– 233.

13. Schlender, J.,, G. Walliser,, J. Fricke,, and K. K. Conzelmann. 2002. Respiratory syncytial virus fusion protein mediates inhibition of mitogen-induced T-cell proliferation by contact. J. Virol. 76: 1163– 1170.

14. Simoes, E. A.,, A. R. Hayward,, E. A. Ponnuraj,, J. P. Straumanis,, K. R. Stenmark,, H. L. Wilson,, and P. G. Babu. 1999. Respiratory syncytial virus infects the Bonnet monkey, Macaca radiata. Pediatr. Dev. Pathol. 2: 316– 326.

15. Smee, D. F.,, and T. R. Matthews. 1986. Metabolism of ribavirin in respiratory syncytial virusinfected and uninfected cells. Antimicrob. Agents Chemother. 30: 117– 121.

16. Tripp, R. A.,, D. Moore,, J. Winter,, and L. J. Anderson. 2000. Respiratory syncytial virus infection and G and/or SH protein expression contribute to substance P, which mediates inflammation and enhanced pulmonary disease in BALB/c mice. J. Virol. 74: 1614– 1622.

17. Weltzin, R.,, V. Traina-Dorge,, K. Soike,, J. Y. Zhang,, P. Mack,, G. Soman,, G. Drabik,, and T. P. Monath. 1996. Intranasal monoclonal IgA antibody to respiratory syncytial virus protects rhesus monkeys against upper and lower respiratory tract infection. J. Infect. Dis. 174: 256– 261.

1. Halaihel, N.,, V. Lievin,, J. M. Ball,, M. K. Estes,, F. Alvarado,, and M. Vasseur. 2000. Direct inhibitory effect of rotavirus NSP4 (114-135) peptide on the Na +-D-glucose symporter of rabbit intestinal brush border membrane. J. Virol. 74: 9464– 9470.

2. Hjelt, K.,, P. C. Grauballe,, A. Paerregaard,, O. H. Nielsen,, and P. A. Krasilnikoff. 1987. Protective effect of preexisting rotavirus-specific immunoglobulin A against naturally acquired rotavirus infection in children. J. Med. Virol. 21: 39– 47.

3. Katyal, R.,, S. V. Rana,, K. Vaiphei,, S. Ohja,, K. Singh,, and V. Singh. 1999. Effect of rotavirus infection on small gut pathophysiology in a mouse model. J. Gastroenterol. Hepatol. 14: 779– 784.

4. Katyal, R.,, S. Rana,, K. Vaiphei,, S. Ojha,, V. Singh,, and K. Singh. 2001. Effect of rotavirus infection on lipid composition and glucose uptake in infant mouse intestine. Indian J. Gastroenterol. 20: 18– 21.

5. Mansfield, K.,, and N. King,. 1998. Viral diseases, p. 1– 57. In B. T. Bennett, , C. R. Abee, , and R. Henrickson (ed.), Nonhuman Primates in Biomedical Research. Diseases. Academic Press, Inc., San Diego, Calif.

6. Michelangeli, F.,, M. C. Ruiz,, J. R. del Castillo,, J. E. Ludert,, and F. Liprandi. 1991. Effect of rotavirus infection on intracellular calcium homeostasis in cultured cells. Virology 181: 520– 527.

7. Mitchell, J. D.,, L. A. Lambeth,, L. Sosula,, A. Murphy,, and M. Albrey. 1977. Transmission of rotavirus gastroenteritis from children to a monkey. Gut 18: 156– 160.

8. Moe, K.,, and G. J. Harper. 1983. The effect of relative humidity and temperature on the survival of bovine rotavirus in aerosol. Arch. Virol. 76: 211– 216.

9. Ojeh, C. K.,, T. M. Cusack,, and R. H. Yolken. 1995. Evaluation of the effects of disinfectants on rotavirus RNA and infectivity by the polymerase chain reaction and cell-culture methods. Mol. Cell. Probes 9: 341– 346.

10. Soike, K. F.,, G. W. Gary,, and S. Gibson. 1980. Susceptibility of nonhuman primate species to infection by simian rotavirus SA-11. Am. J. Vet. Res. 41: 1098– 1103.

11. Thouless, M. E.,, R. F. DiGiacomo,, and B. J. Deeb. 1996. The effect of combined rotavirus and Escherichia coli infections in rabbits. Lab. Anim. Sci. 46: 381– 385.

12. Unicomb, L. E.,, S. M. Faruque,, M. A. Malek,, A. S. Faruque,, and M. J. Albert. 1996. Demonstration of a lack of synergistic effect of rotavirus with other diarrheal pathogens on severity of diarrhea in children. J. Clin. Microbiol. 34: 1340– 1342.

13. Weclewicz, K.,, K. Kristensson,, and L. Svensson. 1994. Rotavirus causes selective vimentin reorganization in monkey kidney CV-1 cells. J. Gen. Virol. 75: 3267– 3271.

14. Winiarczyk, S.,, and Z. Gradzki. 1999. Comparison of polymerase chain reaction and dot hybridization with enzyme-linked immunoassay, virological examination and polyacrylamide gel electrophoresis for the detection of porcine rotavirus in faecal specimens. Zentbl. Vetmed. Reihe B 46: 623– 634.

15. Wyatt, R. G.,, D. L. Sly,, W. T. London,, A. E. Palmer,, A. R. Kalica,, D. H. Kirk,, R. M. Chanock,, and A. Z. Kapikian. 1976. Induction of diarrhea in colostrum deprived newborn rhesus monkeys with the human reovirus-like agent in infantile gastroenteritis. Arch. Virol. 50: 17– 27.

16. Zhang, M.,, C. Q. Zeng,, A. P. Morris,, and M. K. Estes. 2000. A functional NSP4 enterotoxin peptide secreted from rotavirus-infected cells. J. Virol. 74: 11663– 11670.

1. Allen, A. M.,, A. E. Palmer,, N. M. Tauraso,, and A. Shelokov. 1968. Simian hemorrhagic fever. II. Studies in pathology. Am. J. Trop. Med. Hyg. 17: 413– 421.

2. Godeny, E. K. 2002. Enzyme-linked immunosorbent assay for detection of antibodies against simian hemorrhagic fever virus. Comp. Med. 52: 229– 232.

3. Gravell, M.,, W. T. London,, M. Leon,, A. E. Palmer,, and R. W. Hamilton. 1986. Elimination of persistent simian hemorrhagic fever (SHF) virus infection in patas monkeys. Proc. Soc. Exp. Biol. Med. 181: 219– 225.

4. Gravell, M.,, A. E. Palmer,, M. Rodriguez,, W. T. London,, and R. S. Hamilton. 1980. Method to detect asymptomatic carriers of simian hemorrhagic fever virus. Lab. Anim. Sci. 30: 988– 991.

5. London, W. T. 1977. Epizootology, transmission and approach to prevention of fatal simian hemorrhagic fever virus in rhesus monkeys. Nature (London) 268: 344– 345.

6. Mansfield, K.,, and N. King,. 1998. Viral diseases, p. 1– 57. In B. T. Bennett, , C. R. Abee, , and R. Henrickson (ed.), Nonhuman Primates in Biomedical Research. Diseases. Academic Press, Inc., San Diego, Calif.

7. Palmer, A. E.,, A. M. Allen,, N. M. Tauraso,, and S. Shelokov. 1968. Simian hemorrhagic fever. I. Clinical and epizootiologic aspects of an outbreak among quarantined monkeys. Am. J. Trop. Med. Hyg. 17: 404– 412.

8. Renquist, D. 1990. Outbreak of simian hemorrhagic fever, J. Med. Primatol. 19: 77– 80.

9. Weiland, E.,, and F. Weiland. 2002. Autoantibodies against golgi apparatus induced by arteriviruses. Cell. Mol. Biol. 48: 279– 284.

1. Alpers, C. E.,, C. C. Tsai,, K. L. Hudkins,, Y. Cui,, L. Kuller,, R. E. Benveniste,, J. M. Ward,, and W. R. Morton. 1997. Focal segmental glomerulosclerosis in primates infected with a simian immunodeficiency virus. AIDS Res. Hum. Retrovir. 13: 413– 424.

2. Baskerville, A.,, A. D. Ramsay,, B. J. Addis,, M. J. Dennis,, R. W. Cook,, M. P. Cranage,, and P. J. Greenaway. 1992. Interstitial pneumonia in simian immunodeficiency virus infection. J. Pathol. 167: 241– 247.

3. Baskin, G. B.,, M. Murphey-Corb,, L. N. Martin,, B. Davison-Fairburn,, F. S. Hu,, and D. Kuebler. 1991. Thymus in simian immunodeficiency virus-infected rhesus monkeys. Lab. Investig. 65: 400– 407.

4. Chalifoux, L. V.,, M. A. Simon,, D. R. Pauley,, J. J. MacKey,, M. S. Wyand,, and D. J. Ringler. 1992. Arteriopathy in macaques infected with simian immunodeficiency virus. Lab. Investig. 67: 338– 349.

5. Chen, Z.,, P. Zhou,, D. D. Ho,, N. R. Landau,, and P. A. Marx. 1997. Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry. J. Virol. 71: 2705– 2714.

6. Desrosiers, R. C. 1990. HIV-1 origins, a finger on the missing link. Nature 345: 288– 289.

7. Gerber, M. A.,, M. L. Chen,, F. S. Hu,, G. B. Baskin,, and L. Petrovich. 1991. Liver disease in rhesus monkeys infected with simian immunodeficiency virus. Am. J. Pathol. 139: 1081– 1088.

8. Gold, L. H.,, H. S. Fox,, S. J. Henriksen,, M. J. Buchmeier,, M. R. Weed,, M. S. Taffe,, S. Huitron-Resendiz,, T. F. Horn,, and F. E. Bloom. 1998. Longitudinal analysis of behavioral, neurophysiological, viral and immunological effects of SIV infection in rhesus monkeys. J. Med. Primatol. 27: 104– 112.

9. Hayami, M.,, E. Ido,, and T. Miura. 1994. Survey of simian immunodeficiency virus among nonhuman primate populations. Curr. Top. Microbiol. Immunol. 188: 1– 20.

10. Heise, C.,, P. Vogel,, C. J. Miller,, C. H. Halsted,, and S. Dandekar. 1993. Simian immunodeficiency virus infection of the gastrointestinal tract of rhesus macaques. Functional, pathological, and morphological changes. Am. J. Pathol. 142: 1759– 1771.

11. Kestens, L.,, J. Vingerhoets,, M. Peeters,, G. Vanham,, C. Vereecken,, G. Penne,, H. Niphuis,, P. van Eerd,, G. van der Groen,, P. Gigase,, and J. Heeney. 1995. Phenotypic and functional parameters of cellular immunity in a chimpanzee with a naturally acquired simian immunodeficiency virus infection. J. Infect. Dis. 172: 957– 963.

12. Kewenig, S.,, T. Schneider,, K. Hohloch,, K. Lampe-Dreyer,, R. Ullrich,, N. Stolte,, C. Stahl-Hennig,, F. J. Kaup,, A. Stallmach,, and M. Zeitz. 1999. Rapid mucosal CD4 + T-cell depletion and enteropathy in simian immunodeficiency virus-infected rhesus macaques. Gastroenterology 116: 1115– 1123.

13. Lackner, A. A. 1994. Pathology of simian immunodeficiency virus induced disease. Curr. Top. Microbiol. Immunol. 188: 35– 64.

14. Larimore, M. D.,, J. E. Kaplan,, M. D. Daniel,, N. W. Lerche,, P. L. Nara,, H. M. Mc-Clure,, J. W. McVivar,, R. W. McKinney,, M. Hendry,, P. Gerone,, M. Rayfield,, J. Allan,, J. L. Ribas,, H. J. Klein,, P. B. Jahrling,, and B. Brown. 1989. Guidelines for the prevention of simian immunodeficiency virus infection in laboratory workers and handlers. J. Med. Primatol. 18: 167– 174.

15. Lerche, N. W.,, J. L. Yee,, and M. B. Jennings. 1994. Establishing specific retrovirus-free breeding colonies of macaques: An aproach to primary screening and surveillance. Lab. Anim. Sci. 44: 217– 221.

16. Mansfield, K.,, and N. King,. 1998. Viral diseases, p. 1– 57. In B. T. Bennett, , C. R. Abee, , and R. Henrickson (ed.), NonhumanPrimates in Biomedical Research. Diseases. Academic Press, Inc., San Diego, Calif.

17. Mansfield, K. G.,, K. C. Lin,, J. Newman,, D. Schauer,, J. MacKey,, A. A. Lackner,, and A. Carville. 2001. Identification of enteropathogenic Escherichia coli in simian immunodeficiency virus-infected infant and adult rhesus macaques. J. Clin. Microbiol. 39: 971– 976.

18. McClure, M. O.,, T. F. Schulz,, R. S. Tedder,, J. Gow,, J. A. McKeating,, R. A. Weiss,, and A. Baskerville. 1989. Inoculation of new world primates with human immunodeficiency virus. J. Med. Primatol. 18: 329– 335.

19. Miller, C. J.,, P. Vogel,, N. J. Alexander,, S. Dandekar,, A. G. Hendrickx,, and P. A. Marx. 1994. Pathology and localization of simian immunodeficiency virus in the reproductive tract of chronically infected male rhesus macaques. Lab. Investig. 70: 255– 262.

20. Montgomery, M. M.,, A. F. Dean,, F. Taffs,, E. J. Stott,, P. L. Lantos,, and P. J. Luthert. 1999. Progressive dendritic pathology in cynomolgus macaques infected with simian immunodeficiency virus. Neuropathol. Appl. Neurobiol. 25: 11– 19.

21. Munch, J.,, N. Stolte,, D. Fuchs,, C. Stahl-Hennig,, and F. Kirchhoff. 2001. Efficient class I major histocompatibility complex down-regulation by simian immunodeficiency virus Nef is associated with a strong selective advantage in infected rhesus macaques. J. Virol. 75: 10532– 10536.

22. Nadler, R. D.,, A. D. Manocha,, and H. M. McClure. 1993. Spermatogenesis and hormone levels in rhesus macaques inoculated with simian immunodeficiency virus. J. Med. Primatol. 22: 325– 329.

23. Poaty-Mavoungou, V.,, F. S. Toure,, C. Tevi-Benissan,, and E. Mavoungou. 2002. Enhancement of natural killer cell activation and antibody-dependent cellular cytotoxicity by interferon-alpha and interleukin-12 in vaginal mucosae SIVmac251-infected Macaca fascicularis. Viral Immunol. 15: 197– 212.

24. Pope, T. W.,, L. Raymond,, L. Foresman,, D. Pinson,, S. V. Joag,, J. Marcario,, N. E. Berman,, R. Raghavan,, P. D. Cheney,, O. Narayan,, S. Wilkinson,, and M. A. Gordon. 1997. Texture analysis of cerebral white matter in SIV-infected macaque monkeys. J. Neurosci. Methods 74: 53– 64.

25. Shannon, R. P.,, M. A. Simon,, M. A. Mathier,, Y. J. Geng,, S. Mankad,, and A. A. Lackner. 2000. Dilated cardiomyopathy associated with simian AIDS in nonhuman primates. Circulation 101: 185– 193.

26. Sopper, S.,, M. Demuth,, C. Stahl-Hennig,, G. Hunsmann,, R. Plesker,, C. Coulibaly,, S. Czub,, M. Ceska,, E. Koutsilieri,, P. Riederer,, R. Brinkmann,, M. Katz,, and V. ter Meulen. 1996. The effect of simian immunodeficiency virus infection in vitro and in vivo on the cytokine production of isolated microglia and peripheral macrophages from rhesus monkey. Virology 220: 320– 329.

27. Westmoreland, S. V.,, E. Halpern,, and A. A. Lackner. 1998. Simian immunodeficiency virus encephalitis in rhesus macaques is associated with rapid disease progression. J. Neurovirol. 4: 260– 268.

28. Zimmer, M. I.,, A. T. Larregina,, C. M. Castillo,, S. Capuano III, , L. D. Falo, Jr.,, M. Murphey-Corb, , T. A. Reinhart, , and S. M. Barratt-Boyes. 2002. Disrupted homeostasis of Langerhans cells and interdigitating dendritic cells in monkeys with AIDS. Blood 99: 2859– 2868.

1. Cheung, A. T.,, and M. B. Gardner. 1991. Functional deficiency of polymorphonuclear leukocytes in simian acquired immunodeficiency syndrome. Am. J. Vet. Res. 52: 1523– 1526.

2. Fikes, J. D.,, and M. G. O’Sullivan. 1995. Localized retroperitoneal fibromatosis causing intestinal obstruction in a cynomolgus monkey ( Macaca fascicularis). Vet. Pathol. 32: 713– 716.

3. Guzman, R. E.,, R. L. Kerlin,, and T. E. Zimmerman. 1999. Histologic lesions in cynomolgus monkeys ( Macaca fascicularis) naturally infected with simian retrovirus type D: comparison of seropositive, virus-positive, and uninfected animals. Toxicol. Pathol. 27: 672– 677.

4. Heyes, M. P.,, M. Gravell,, W. T. London,, M. Eckhaus,, J. H. Vickers,, J. A. Yergey,, M. April,, D. Blackmore,, and S. P. Markey. 1990. Sustained increases in cerbrospinal fluid quinolinic acid concentrations in rhesus macaques ( Macaca mulatta) naturally infected with simian retrovirus type-D. Brain Res. 531: 148– 158.

5. Kwang, H. S.,, N. C. Pedersen,, N. W. Lerche,, K. G. Osborn,, P. A. Marx,, and M. B. Gardner. 1987. Viremia, antigenemia, and serum antibodies in rhesus macaques infected with simian retrovirus type 1 and their relationship to disease course. Lab. Investig. 56: 591– 597.

6. Lackner, A. A.,, M. Schiodt,, G. C. Armitage,, P. E. Moore,, R. J. Munn,, P. A. Marx,, M. G. Gardner,, and L. J. Lowenstine. 1989. Mucosal epithelial cells and langerhans cells are targets for infection by the immunosuppressive type D retrovirus Simian AIDS retrovirus serotype 1. J. Med. Primatol. 18: 195– 207.

8. Maul, D. H.,, C. P. Zaiss,, M. R. Mackenzie,, S. M. Shigi,, P. A. Marx,, and M. G. Gardner. 1988. Simian retrovirus D serotype 1 has a broad cellular tropism for lymphoid and nonlymphoid cells. J. Virol. 62: 1768– 1773.

9. Moazed, T. C.,, and M. E. Thouless. 1993. Viral persistence of simian type D retrovirus (SRV-2/W) in naturally infected pigtailed macaques ( Macaca nemestrina). J. Med. Primatol. 22: 382– 389.

10. Osborn, K. G.,, S. Prahalada,, L. J. Lowenstine,, M. B. Gardner,, D. H. Maul,, and R. V. Henrickson. 1984. The pathology of an epizootic of acquired immunodeficiency in rhesus macaques. Am. J. Pathol. 114: 94– 103.

11. Paramastri, Y. A.,, J. M. Wallace,, K. J. Salleng,, L. M. Wilkinson,, D. E. Malarkey,, and J. M. Cline. 2002. Intracranial lymphomas in simian retrovirus-positive Macaca fascicularis. Vet. Pathol. 39: 399– 402.

12. Roodman, S. T.,, M. D. Woon,, J. W. Hoffman,, P. Theodorakis,, C. C. Tsai,, H. N. Wu,, and C. C. Tsai. 1991. Interleukin-6 and retroperitoneal fibromatosis from SRV-2-infected macaques with simian AIDS. J. Med. Primatol. 20: 201– 205.

13. Schroder, M. A.,, S. K. Fisk,, and N. W. Lerche. 2000. Eradication of simian retrovirus type D from a colony of cynomolgus, rhesus, and stump-tailed macaques by using serial testing and removal. Contemp. Top. Lab. Anim. Sci. 39: 16– 23.

14. Tsai, C. C.,, K. E. Follis,, K. Snyder,, S. Windsor,, M. E. Thouless,, L. Kuller,, and W. R. Morton. 1990. Maternal transmission of type D simian retrovirus (SRV-2) in pigtailed macaques. J. Med. Primatol. 19: 203– 216.

15. Wang, Y.,, and M. E. Thouless. 1996. Use of polymerase chain reaction for diagnosis of type D retrovirus infection in macaque blood. Lab. Anim. Sci. 46: 187– 192.

16. Wilson, B. J.,, S. M. Shiigi,, J. L. Zeigler,, L. C. Olson,, A. Malley, , and C. F. Howard, Jr. 1986. Transmission of simian acquired immunodeficiency syndrome with a type D retrovirus: immunological aspects. Clin. Immunol. Immunopathol. 41: 453– 460.

1. Dezzutti, C. S.,, D. E. Frazier,, and R. G. Olsen. 1990. Efficacy of an HTLV-1 subunit vaccine in prevention of a STLV-1 infection in pig-tailed macaques. Dev. Biol. Stand. 72: 287– 296.

2. Gessain, A.,, and R. Mahieux. 2000. Epidemiology, origin and genetic diversity of HTLV-1 retroviruses and STLV-1 simian affiliated retroviruses. Bull. Soc. Pathol. Exot. 93: 163– 171.

3. Hubbard, G. B.,, J. P. Moné,, J. S. Allan, , K. J. Davis III,, M. M. Leland,, P. M. Banks,, and B. Smir. 1993. Spontaneously generated non-Hodgkin’s lymphoma in twenty-seven simian T-cell leukemia virus type 1 antibody-positive baboons ( Papio species). Lab. Anim. Sci. 43: 301– 309.

4. Lerche, N. W.,, J. L. Yee,, and M. B. Jennings. 1994. Establishing specific retrovirus-free breeding colonies of macaques: An aproach to primary screening and surveillance. Lab. Anim. Sci. 44: 217– 221.

5. Liska, V.,, P. N. Fultz,, L. Su,, and R. M. Ruprecht. 1997. Detection of simian T-cell leukemia virus type 1 infection in seronegative macaques. AIDS Res. Hum. Retrovir. 13: 1147– 1153.

6. Mahieux, R.,, C. Chapey,, M. C. Georges-Courbot,, G. Dubreuil,, P. Mauclere,, A. Georges,, and A. Gessain. 1998. Simian T-cell lymphotropic virus type 1 from Mandrillus sphinx as a simian counterpart of human T-cell lymphotropic virus type 1 subtype D. J. Virol. 72: 10316– 10322.

7. Mansfield, K.,, and N. King,. 1998. Viral diseases, p. 1– 57. In B. T. Bennett, , C. R. Abee, and R. Henrickson (ed.), Nonhuman Primates in Biomedical Research. Diseases. Academic Press, Inc., San Diego, Calif.

8. McCarthy, T. J.,, J. L. Kennedy,, J. R. Blakeslee,, and B. T. Bennett. 1990. Spontaneous malignant lymphoma and leukemia in a simian T-lymphotropic virus type 1 (STLV-1) antibody positive olive baboon. Lab. Anim. Sci. 40: 79– 81.

9. Noda, Y.,, K. Ishikawa,, A. Sasagawa,, S. Honjo,, S. Mori,, H. Tsujimoto,, and M. Hayami. 1986. Hematologic abnormalities similar to the preleukemic state of adult T-cell leukemia in African green monkeys naturally infected with simian T-cell leukemia virus. Jpn. J. Cancer Res. 77: 1227– 1234.

10. Takemura, T.,, M. Yamashita,, M. K. Shimada,, S. Ohkura,, T. Shotake,, M. Ikeda,, T. Miura,, and M. Hayami. 2002. High prevalence of simian T-lymphotropic virus type L in wild ethiopian baboons. J. Virol. 76: 1642– 1648.

11. Voevodin, A.,, E. Samilchuk,, H. Schatzl,, E. Boeri,, and G. Franchini. 1996. Interspecies transmission of macaque simian T-cell leukemia/ lymphoma virus type 1 in baboons resulted in an outbreak of malignant lymphoma. J. Virol. 70: 1633– 1639.

1. Andrei, G.,, R. Snoeck,, M. Vandeputte,, and E. De Clercq. 1997. Activities of various compounds against murine and primate polyomaviruses. Antimicrob. Agents Chemother. 41: 587– 593.

2. Horvath, C. J.,, M. A. Simon,, D. J. Bergsagel,, D. R. Pauley,, N. W. King,, R. L. Garcea,, and D. J. Ringler. 1992. Simian virus 40-induced disease in rhesus monkeys with simian acquired immunodeficiency syndrome. Am. J. Pathol. 140: 1431– 1440.

3. Hurley, J. P.,, P. O. Ilyinskii,, C. J. Horvath,, and M. A. Simon. 1997. A malignant astrocytoma containing simian virus 40 DNA in a macaque infected with simian immunodeficiency virus. J. Med. Primatol. 26: 172– 180.

4. Mansfield, K.,, and N. King,. 1998. Viral diseases, p. 1– 57. In B. T. Bennett, , C. R. Abee, , and R. Henrickson (ed.), Nonhuman Primates in Biomedical Research. Diseases. Academic Press, Inc., San Diego, Calif.

5. Newman, J. S.,, G. B. Baskin,, and R. J. Frisque. 1998. Identification of SV40 in brain, kidney and urine of healthy and SIV-infected rhesus macaques. J. Neurovirol. 4: 394– 406.

6. Simon, M. A.,, P. O. Ilyinskii,, G. B. Baskin,, H. Y. Knight,, D. R. Pauley,, and A. A. Lackner. 1999. Association of simian virus 40 with a central nervous system lesion distinct from progressive multifocal leukoencephalopathy in macaques with AIDS. Am. J. Pathol. 154: 437– 446.

1. Baqar, S.,, A. L. Bourgeois,, P. J. Schultheiss,, R. I. Walker,, D. M. Rollins,, R. L. Haberberger,, and O. R. Pavlovskis. 1995. Safety and immunogenicity of a prototype oral whole-cell killed Campylobacter vaccine administered with a mucosal adjuvant in non-human primates. Vaccine 13: 22– 28.

2. Englen, M. D.,, and L. C. Kelley. 2000. A rapid DNA isolation procedure for the identification of Campylobacter jejuni by the polymerase chain reaction. Lett. Appl. Microbiol. 31: 421– 426.

3. Everest, P. H.,, A. T. Cole,, C. J. Hawkey,, S. Knutton,, H. Goossens,, J. P. Butzler,, J. M. Ketley,, and P. H. Williams. 1993. Roles of leukotrienes B 4, prostaglandin E 2, and cyclic AMP in Campylobacter jejuni-induced intestinal fluid secretion. Infect. Immun. 61: 4885– 4887.

4. Fitzgeorge, R. B.,, A. Baskerville,, and K. P. Lander. 1981. Experimental infection of rhesus monkeys with a human strain of Campylobacter jejuni. J. Hyg. 86: 343– 351.

5. George, J. W.,, and N. W. Lerche. 1990. Electrolyte abnormalities associated with diarrhea in rhesus monkeys: 100 cases (1986-1987). J. Am. Vet. Med. Assoc. 196: 1654– 1658.

6. Gibson, S. V., 1998. Bacterial and mycotic diseases, p. 59– 110. In B. T. Bennett, , C. R. Abee, , and R. Henrickson (ed.), Nonhuman Primates in Biomedical Research. Diseases. Academic Press, Inc., San Diego, Calif.

7. Klipstein, F. A.,, R. F. Engert,, H. Short,, and E. A. Schenk. 1985. Pathogenic properties of Campylobacter jejuni: Assay and correlation with clinical manifestations. Infect. Immun. 50: 43– 49.

8. Lyte, M.,, J. J. Varcoe,, and M. T. Bailey. 1998. Anxiogenic effect of subclinical bacterial infection in mice in the absence of overt immune activation. Physiol. Behav. 65: 63– 68.

9. O’Sullivan, A. M.,, C. J. Dore,, S. Boyle,, C. R. Coid,, and A. P. Johnson. 1988. The effect of Campylobacter lipopolysaccharide on fetal development in the mouse. J. Med. Microbiol. 26: 101– 105.

10. Pancorbo, P. L.,, M. A. de Pablo,, E. Ortega,, A. M. Gallego,, C. Alvarez,, and G. Alvarez de Cienfuegos. 1999. Evaluation of cytokine production and phagocytic activity in mice infected with Campylobacter jejuni. Curr. Microbiol. 39: 129– 133.

11. Russell, R. G.,, M. J. Blaser,, J. I. Sarmiento,, and J. Fox. 1989. Experimental Campylobacter jejuni infection in Macaca nemestrina. Infect. Immun. 57: 1438– 1444.

12. Russell, R. G.,, M. O’Donnoghue, , D. C. Blake, Jr.,, J. Zulty, , and L. J. DeTolla. 1993. Early colonic damage and invasion of Campylobacter jejuni in experimentally challenged infant Macaca mulatta. J. Infect. Dis. 168: 210– 215.

13. Russell, R. G.,, S. L. Rosenkranz,, L. A. Lee,, H. Howard,, R. F. DiGiacomo,, M. A. Bronsdon,, G. A. Blakley,, C. C. Tsai,, and W. R. Morton. 1987. Epidemiology and etiology of diarrhea in colony-born Macaca nemistrina. Lab. Anim. Sci. 37: 309– 316.

14. Torres, O.,, and J. R. Cruz. 1993. Protection against Campylobacter diarrhea: role of milk IgA antibodies against bacterial surface antigens. Acta Paediatr. 82: 835– 838.

1. Al-Hasani, K.,, I. R. Henderson,, H. Sakellaris,, K. Rajakumar,, T. Grant,, J. P. Nataro,, R. Robins-Browne,, and B. Adler. 2000. The sigA gene which is borne on the she pathogenicity island of Shigella flexneri 2a encodes an exported cytopathic protease involved in intestinal fluid accumulation. Infect. Immun. 68: 2457– 2463.

2. Banish, L. D.,, R. Sims,, D. Sack,, R. J. Montali, , L. Phillips, Jr.,, and M. Bush. 1993. Prevalence of shigellosis and other enteric pathogens in a zoologic collection of primates. J. Am. Vet. Med. Assoc. 203: 126– 132.

3. Formal, S. B.,, E. V. Oaks,, F. E. Olsen,, M. Wingfield-Eggleston,, P. J. Snoy,, and J. P. Cogan. 1991. Effect of prior infection with virulent Shigella flexneri 2a on the resistance of monkeys to subsequent infection with Shigella sonnei. J. Infect. Dis. 164: 533– 537.

4. Frankel, G.,, L. Riley,, J. A. Giron,, J. Valmassoi,, A. Friedmann,, N. Strockbine,, S. Falkow,, and G. K. Schoolnik. 1990. Detection of Shigella in feces using DNA amplification. J. Infect. Dis. 161: 1252– 1256.

5. Gibson, S. V., 1998. Bacterial and mycotic diseases, p. 59– 110. In B. T. Bennett, , C. R. Abee, , and R. Henrickson (ed.), Nonhuman Primates in Biomedical Research. Diseases. Academic Press, Inc., San Diego, Calif.

6. Guichon, A.,, D. Hersh,, M. R. Smith,, and A. Zychlinsky. 2001. Structure-function analysis of the Shigella virulence factor IpaB. J. Bacteriol. 183: 1269– 1276.

7. Henderson, I. R.,, J. Czeczulin,, C. Eslava,, F. Noriega,, and J. P. Nataro. 1999. Characterization of pic, a secreted protease of Shigella flexneri and enteroaggregative Escherichia coli. Infect. Immun. 67: 5587– 5596.

8. Karnell, A.,, F. P. Reinholt,, S. Katakura,, and A. A. Lindberg. 1991. Shigella flexneri infection: a histopathologic study of colonic biopsies in monkeys infected with virulent and attenuated bacterial strains. APMIS 99: 787– 796.

9. Katakura, S.,, F. P. Reinholt,, A. Karnell,, P. T. Huan,, D. D. Trach,, and A. A. Lindberg. 1990. The pathology of Shigella flexneri infection in rhesus monkeys: an endoscopic and histopathological study of colonic lesions. APMIS 98: 313– 319.

10. Kennedy, F. M.,, J. Astbury,, J. R. Needham,, and T. Cheasty. 1993. Shigellosis due to occupational contact with non-human primates. Epidemiol. Infect. 110: 247– 251.

11. McClure, H. M.,, P. Alford,, and B. Swenson. 1976. Nonenteric Shigella infections in nonhuman primates. J Am. Vet. Med. Assoc. 169: 938– 939.

12. Mogull, S. A.,, L. J. Runyen-Janecky,, M. Hong,, and S. M. Payne. 2001. dksA is required for intercellular spread of Shigella flexneri via an RpoS-independent mechanism. Infect. Immun. 69: 5742– 5751.

13. Mulder, J. B. 1971. Shigellosis in nonhuman primates: A review. Lab. Anim. Sci. 21: 734– 738.

14. Picking, W. L.,, L. Coye,, J. C. Osiecki,, A. Barnoski Serfis,, E. Schaper,, and W. D. Picking. 2001. Identification of functional regions within invasion plasmid antigen C (IpaC) of Shigella flexneri. Mol. Microbiol. 39: 100– 111.

15. Rout, W. R.,, S. B. Formal,, R. A. Giannella,, and G. J. Dammin. 1975. Pathophysiology of Shigella diarrhea in the rhesus monkey: intestinal transport, morphological, and bacteriological studies. Gastroenterology 68: 270– 278.

16. Sansonetti, P. J.,, J. Arondel,, J. R. Cantey,, M. C. Prevost,, and M. Huerre. 1996. Infection of rabbit Peyer’s patches by Shigella flexneri: effect of adhesive or invasive bacterial phenotypes on follicle-associated epithelium. Infect. Immun. 64: 2752– 2764.

17. Sansonetti, P. J.,, J. Arondel,, J. M. Cavaillon,, and M. Huerre. 1995. Role of interleukin-1 in pathogenesis of experimental shigellosis. J. Clin. Invest. 96: 884– 892.

18. Takeuchi, A. 1982. Early colonic lesions in experimental Shigella infection in rhesus monkeys: revisited. Vet. Pathol. Suppl. 7: 1– 8.

19. Thapa, B. R.,, K. Ventkateswarlu,, A. K. Malik,, and D. Panigrahi. 1995. Shigellosis in children from north India: a clinicopathological study. J. Trop. Pediatr. 41: 303– 307.

20. Venkatesan, M. M.,, A. B. Hartman,, J. W. Newland,, V. S. Ivanova,, T. L. Hale,, M. McDonough,, and J. Butterton. 2002. Construction, characterization, and animal testing of WRSd1, an Shigella dysenteriae 1 vaccine. Infect. Immun. 70: 2950– 2958.

21. Zhong, Q. P. 1999. Pathogenic effects of O-polysaccharide from Shigella flexneri strain. World J. Gastroenterol. 5: 245– 248.

1. Abe, S.,, K. Ishihara,, and K. Okuda. 2001. Prevalence of potential respiratory pathogens in the mouths of elderly patients and effects of professional oral care. Arch. Gerontol. Geriatr. 32: 45– 55.

2. Berendt, R. F.,, G. C. Long,, and J. S. Walker. 1975. Influenza alone and in sequence with pneumonia due to Streptococcus pneumoniae in the squirrel monkey. J. Infect. Dis. 132: 689– 693.

3. Biberstein, E. L.,, and D. C. Hirsh 1999,. Streptococci, p. 120– 126. In D. C. Hirsh, and Y. C. Zee (ed.), Veterinary Microbiology. Blackwell Science, Inc., Malden, Mass.

4. Cockeran, R.,, C. Durandt,, C. Feldman,, T. J. Mitchell,, and R. Anderson. 2002. Pneumolysin activates the synthesis and release of interleukin-8 by human neutrophils in vitro. J. Infect. Dis. 186: 562– 565.

5. Comis, S. D.,, M. P. Osborne,, J. Stephen,, M. J. Tarlow,, T. L. Hayward,, T. J. Mitchell,, P. W. Andrew,, and G. J. Boulnois. 1993. Cytotoxic effects on hair cells of guinea pig cochlea produced by pneumolysin, the thiol activated toxin of Streptococcus pneumoniae. Acta Otolaryngol. 113: 152– 159.

7. Graczyk, T. K.,, M. R. Cranfield,, S. E. Kempske,, and M. A. Eckhaus. 1995. Fulminant Streptococcus pneumoniae meningitis in a lion-tailed macaque ( Macaca silenus) without detected signs. J. Wildl. Dis. 31: 75– 78.

8. Hawley, H. B.,, T. Yamada,, D. F. Mosher,, D. P. Fine,, and R. F. Berendt. 1977. Disseminated intravascular coagulopathy during experimental pneumococcal sepsis: studies in normal and asplenic rhesus monkeys. J. Med. Primatol. 6: 203– 218.

9. Kragsbjerg, P.,, and H. Fredlund. 2001. The effects of live Streptococcus pneumoniae and tumor necrosis factor-alpha on neutrophil oxidative burst and beta 2-integrin expression. Clin. Microbiol. Infect. 7: 125– 129.

10. Padovan, D.,, and C. Cantrell. 1980. Causes of death of infant rhesus and squirrel monkeys. J. Am. Vet. Med. Assoc. 183: 1182– 1184.

11. Solleveld, H. A.,, M. J. van Zwieten,, P. J. Heidt,, and P. M. van Eerd. 1984. Clinicopathologic study of six cases of meningitis and meningoencephalitis in chimpanzees ( Pan troglodytes). Lab. Anim. Sci. 34: 86– 90.

12. Wannemacher, R. W., Jr.,, F. A. Beall, , P. G. Canonico, , R. E. Dinterman, , C. L. Hadick, , and H. A. Neufeld. 1980. Glucose and alanine metabolism during bacterial infections in rats and rhesus monkeys. Metabolism. 29: 201– 212.

1. Cummins, L. B.,, M. E. Keeling,, and H. M. McClure. 1973. Preventive medicine in anthropoids: parasite control. Lab. Anim. Sci. 23: 819– 822.

2. Lee, R. V.,, A. W. Prowten,, S. Anthone,, S. K. Satchidanand,, J. E. Fisher,, and R. Anthone. 1990. Typhlitis due to Balantidium coli in captive lowland gorillas. Rev. Infect. Dis. 12: 1052– 1059.

3. Nakauchi, K. 1999. The prevalence of Balantidium coli infection in fifty-six mammalian species. J. Vet. Med. Sci. 61: 63– 65.

4. Soulsby, E. J. L. 1982. Helminths, Arthropods and Protozoa of Domesticated Animals, 7th ed., p. 660– 661. Lea & Febiger, Philadelphia, Pa.

5. Toft, J. D., II,, and M. L. Eberhard,. 1998. Parasitic diseases, p. 111– 205. In B. T. Bennett, , C. R. Abee, , and R. Henrickson (ed.), Nonhuman Primates in Biomedical Research. Diseases. Academic Press, Inc., San Diego, Calif.

1. Beaver, P. C.,, J. L. Blanchard,, and H. R. Seibold. 1988. Invasive amebiasis in naturally infected New World and Old World monkeys with and without clinical disease. Am. J. Trop. Med. Hyg. 39: 343– 352.

2. Beaver, P. C.,, A. L. Villegas,, C. Cuello,, and A. D’Allessandro. 1978. Cutaneous amebiasis of the eyelid with extension into the orbit. Am. J. Trop. Med. Hyg. 27: 1133– 1136.

3. Calore, E. E.,, N. M. Calore,, and M. J. Cavaliere. 2002. Salpingitis due to Entamoeba histolytica. Braz. J. Infect. Dis. 6: 97– 99.

4. Campbell, D.,, D. Gaucher,, and K. Chadee. 1999. Serum from Entamoeba histolytica-infected gerbils selectively suppresses T cell proliferation by inhibiting interleukin-2 production. J. Infect. Dis. 179: 1495– 1501.

5. Chadee, K.,, and E. Meerovitch. 1985. Entamoeba histolytica: lymphoreticular changes in gerbils ( Meriones unguiculatus) with experimentally induced cecal amebiasis. J. Parasitol. 71: 566– 575.

6. Chao, T. H.,, Y. H. Li,, L. M. Tsai,, J. K. Teng,, L. J. Lin,, and J. H. Chen. 1998. Amebic liver abscess complicated with cardiac tamponade and mediastinal abscess. J. Formos. Med. Assoc. 97: 214– 216.

7. Ghosh, P. K.,, S. Gupta,, S. Naik,, A. Ayyagari,, and S. R. Naik. 1998. Effect of bacterial association on virulence of Entamoeba histolytica to baby hamster kidney cell monolayers. Indian J. Exp. Biol. 36: 911– 915.

8. Gomes, M. A.,, M. N. Melo,, G. P. Pena,, and E. F. Silva. 1997. Virulence parameters in the characterization of strains of Entamoeba histolytica. Rev. Inst. Med. Trop. Sao Paulo 39: 65– 69.

9. Leroy, A.,, G. De Bruyne,, A. Verspeelt,, T. Lauwaet,, H. Nelis,, and M. Mareel. 1997. Bacterium-assisted invasion of Entamoeba histolytica through human enteric epithelia in two-compartment chambers. Invasion Metastasis 17: 138– 148.

10. Rico, G.,, O. Diaz-Guerra,, and R. R. Kretschmer. 1995. Cyclic nucleotide changes induced in human leukocytes by a product of axenically grown Entamoeba histolytica that inhibits human monocyte locomotion. Parasitol. Res. 81: 158– 162.

11. Rivera, W. L.,, and H. Kanbara. 1999. Detection of Entamoeba dispar DNA in macaque feces by polymerase chain reaction. Parasitol. Res. 85: 493– 495.

12. Sakakibara, I.,, Y. Sugimoto,, T. Koyama,, and S. Honjo. 1982. Natural transmission of Entamoeba histolytica from mother cynomolgus monkeys ( Macaca fascicularis) to their newborn infants under indoor rearing conditions. Jikken Dobutsu 31: 135– 138.

13. Sanchez-Ramirez, B.,, S. Mata-Gonzalez,, A. Valdez,, E. Ramos-Martinez,, and P. Talamas-Rohana. 2001. Liver function tests during amoebic liver abscess formation in indomethacintreated hamsters. J. Exp. Zool. 290: 201– 206.

14. Soulsby, E. J. L. 1982. Helminths, Arthropods and Protozoa of Domesticated Animals, 7th ed., p. 660– 661. Lea & Febiger, Philadelphia, Pa.

15. Tachibana, H.,, X. J. Cheng,, S. Kobayashi,, N. Matsubayashi,, S. Gotoh,, and K. Matsubayashi. 2001. High prevalence of infection with Entamoeba diapar, but not E. histolytica, in captive macaques. Parasitol. Res. 87: 14– 17.

16. Toft, J. D., II,, and M. L. Eberhard,. 1998. Parasitic diseases, p. 111-205. In B. T. Bennett, , C. R. Abee, , and R. Henrickson (ed.), Nonhuman Primates in Biomedical Research. Diseases. Academic Press, Inc., San Diego, Calif.

17. Trissl, D. 1982. Immunology of Entamoeba histolytica in human and animal hosts. Rev. Infect. Dis. 4: 1154– 1184.

18. Vogel, P.,, G. Zaucha,, S. D. Goodwin,, K. Kuehl,, and D. Fritz. 1996. Rapid postmortem invasion of cecal mucosa of macaques by nonpathogenic Entamoeba chattoni. Am. J. Trop. Med. Hyg. 55: 595– 602.

19. Wang, W.,, and K. Chadee. 1995. Entamoeba histolytica suppresses gamma interferon-induced macrophage class II major histocompatibility complex Ia molecule and I-A β mRNA expression by a prostaglandin E 2-dependent mechanism. Infect. Immun. 63: 1089– 1094.

20. Wang, W.,, K. Keller,, and K. Chadee. 1992. Modulation of tumor necrosis factor production by macrophages in Entamoeba histolytica infection. Infect. Immun. 60: 3169– 3174.

21. Weigel, M. M.,, A. Calle,, R. X. Armijos,, I. P. Vega,, B. V. Bayas,, and C. E. Montenegro. 1996. The effect of chronic intestinal parasitic infection on maternal and perinatal outcome. Int. J. Gynaecol. Obstet. 52: 9– 17.

22. Yu, Y.,, and K. Chadee. 1997. Entamoeba histolytica stimulates interleukin 8 from human colonic epithelial cells without parasite-enterocyte contact. Gastroenterology 112: 1536– 1547.

1. Barrett, K. E.,, F. A. Neva,, A. A. Gam,, J. Cicmanec,, W. T. London,, J. M. Phillips,, and D. D. Metcalfe. 1988. The immune response to nematode parasites: modulation of mast cell numbers and function during Strongyloides stercoralis infections in nonhuman primates. Am. J. Trop. Med. Hyg. 38: 574– 581.

2. Freedman, D. O. 1991. Experimental infection of human subject with Strongyloides species. Rev. Infect. Dis. 13: 1221– 1226.

3. Genta, R. M.,, J. S. Harper III,, A. A. Gam,, W. I. London,, and F. A. Neva. 1984. Experimental disseminated strongyloidiasis in Erythrocebus patas. II. Immunology. Am. J. Trop. Med. Hyg. 33: 444– 450.

4. Harper, J. S., III, R. M. Genta, A. Gam, W. T. London, and F. A. Neva. 1984. Experimental disseminated strongyloidiasis in Erythrocebus patas. I. Pathology. Am. J. Trop. Med. Hyg. 33: 431– 443.

5. Kiyota, M.,, M. Korenaga,, Y. Nawa,, and M. Kotani. 1984. Effect of androgen on the expression of the sex differences in susceptibility to infection with Strongyloides ratti in C57BL/6 mice. Aust. J. Exp. Biol. Med. Sci. 62: 607– 618.

6. Muriuki, S. M.,, R. K. Murugu,, E. Munene,, G. M. Karere,, and D. C. Chai. 1998. Some gastro-intestinal parasites of zoonotic (public health) importance commonly observed in old world non-human primates in Kenya. Acta Trop. 71: 73– 82.

7. Plumelle, Y.,, C. Gonin,, A. Edouard,, B. J. Bucher,, L. Thomas,, A. Brebion,, and G. Panelatti. 1997. Effect of Strongyloides stercoralis infection and eosinophilia on age at onset and prognosis of adult T-cell leukemia. Am. J. Clin. Pathol. 107: 81– 87.

8. Rawat, B.,, and M. E. Simons. 1993. Strongyloides stercoralis hyperinfestation. Another cause of focal hepatic lesions. Clin. Imaging 17: 274– 275.

9. Remfry, J. 1978. The incidence, pathogenesis, and treatment of helminth infections in rhesus monkeys ( Macaca mulatta). Lab. Anim. 12: 213– 218.

10. Rutherford, A. M. 1981. Reflections on the passage of Strongyloides fulleborni to human infants in mothers milk. Trop. Doct. 11: 184– 185.

11. Soulsby, E. J. L. 1982. Helminths, Arthropods and Protozoa of Domesticated Animals, 7th ed., p. 660– 661. Lea & Febiger, Philadelphia, Pa.

12. Toft, J. D., II,, and M. L. Eberhard,. 1998. Parasitic diseases, p. 111-205. In B. T. Bennett, , C. R. Abee, , and R. Henrickson (ed.), Nonhuman Primates in Biomedical Research. Diseases. Academic Press, Inc., San Diego, Calif.

Tables

Pathogens of Nonhuman Primates

Citation: Baker D. 2003. Pathogens of Nonhuman Primates, p 341-376. In Natural Pathogens of Laboratory Animals. ASM Press, Washington, DC. doi: 10.1128/9781555817824.ch11

/content/10.1128/9781555817824.chap11.tab11-1

TABLE 11-1

Body systems known or likely to be affected by pathogen indicated

TABLE 11-1

Body systems known or likely to be affected by pathogen indicated

Citation: Baker D. 2003. Pathogens of Nonhuman Primates, p 341-376. In Natural Pathogens of Laboratory Animals. ASM Press, Washington, DC. doi: 10.1128/9781555817824.ch11